Large-scale testing (Phase 3)Study completedNCT04648241
What this trial is testing
Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older
Who this might be right for
Tick-Borne Encephalitis
Pfizer 165